These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9582544)

  • 1. Overview of olestra: a new fat substitute.
    Hunt R; Zorich NL; Thomson AB
    Can J Gastroenterol; 1998 Apr; 12(3):193-7. PubMed ID: 9582544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the effects of dilution of dietary energy with olestra on energy intake.
    Jandacek RJ
    Physiol Behav; 2012 Mar; 105(5):1124-31. PubMed ID: 22222110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety evaluation of olestra, a nonabsorbed, fatlike fat replacement.
    Bergholz CM
    Crit Rev Food Sci Nutr; 1992; 32(2):141-6. PubMed ID: 1515040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review and analysis of the effects of olestra, a dietary fat substitute, on gastrointestinal function and symptoms.
    Freston JW; Ahnen DJ; Czinn SJ; Earnest DL; Farthing MJ; Gorbach SL; Hunt RH; Sandler RS; Schuster MM
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):210-8. PubMed ID: 9356284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procter & Gamble responds on olestra.
    Middleton SJ
    Public Health Rep; 1999; 114(1):5-6. PubMed ID: 9925160
    [No Abstract]   [Full Text] [Related]  

  • 6. Olestra: a new food additive.
    Prince DM; Welschenbach MA
    J Am Diet Assoc; 1998 May; 98(5):565-9. PubMed ID: 9597030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olestra, a nonabsorbed, noncaloric replacement for dietary fat: a review.
    Lawson KD; Middleton SJ; Hassall CD
    Drug Metab Rev; 1997 Aug; 29(3):651-703. PubMed ID: 9262944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olestra formulation and the gastrointestinal tract.
    Jandacek RJ; Kester JJ; Papa AJ; Wehmeier TJ; Lin PY
    Lipids; 1999 Aug; 34(8):771-83. PubMed ID: 10529087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the nutritional effects of olestra, a nonabsorbed fat replacement: introduction and overview.
    Peters JC; Lawson KD; Middleton SJ; Triebwasser KC
    J Nutr; 1997 Aug; 127(8 Suppl):1539S-1546S. PubMed ID: 9237952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is olestra consumption associated with changes in dietary intake, serum lipids, and body weight?
    Satia-Abouta J; Kristal AR; Patterson RE; Neuhouser ML; Peters JC; Rock CL; Neumark-Sztainer D; Cheskin LJ; Thornquist MD
    Nutrition; 2003 Sep; 19(9):754-9. PubMed ID: 12921885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: olestra and its gastrointestinal safety.
    Thomson AB; Hunt RH; Zorich NL
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1185-200. PubMed ID: 9882026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for olestra in body weight management.
    Eldridge AL; Cooper DA; Peters JC
    Obes Rev; 2002 Feb; 3(1):17-25. PubMed ID: 12119656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing olestra or triglycerides. A 6-week randomized, placebo-controlled trial.
    Sandler RS; Zorich NL; Filloon TG; Wiseman HB; Lietz DJ; Brock MH; Royer MG; Miday RK
    Ann Intern Med; 1999 Feb; 130(4 Pt 1):253-61. PubMed ID: 10068382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmarketing surveillance of new food ingredients: design and implementation of the program for the fat replacer olestra.
    Slough CL; Miday RK; Zorich NL; Jones JK
    Regul Toxicol Pharmacol; 2001 Apr; 33(2):218-23. PubMed ID: 11350204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olestra consumption does not predict serum concentrations of carotenoids and fat-soluble vitamins in free-living humans: early results from the sentinel site of the olestra post-marketing surveillance study.
    Thornquist MD; Kristal AR; Patterson RE; Neuhouser ML; Rock CL; Neumark-Sztainer D; Cheskin LJ
    J Nutr; 2000 Jul; 130(7):1711-8. PubMed ID: 10867041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selling of olestra.
    Nestle M
    Public Health Rep; 1998; 113(6):508-20. PubMed ID: 9847922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of fat in olestra-containing savory snack products by capillary gas chromatography.
    Schul D; Tallmadge D; Burress D; Ewald D; Berger B; Henry D
    J AOAC Int; 1998; 81(4):848-68. PubMed ID: 9680711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in diet, weight, and serum lipid levels associated with olestra consumption.
    Patterson RE; Kristal AR; Peters JC; Neuhouser ML; Rock CL; Cheskin LJ; Neumark-Sztainer D; Thornquist MD
    Arch Intern Med; 2000 Sep; 160(17):2600-4. PubMed ID: 10999973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal symptoms following consumption of olestra or regular triglyceride potato chips: a controlled comparison.
    Cheskin LJ; Miday R; Zorich N; Filloon T
    JAMA; 1998 Jan; 279(2):150-2. PubMed ID: 9440666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmarketing surveillance of new food ingredients: results from the program with the fat replacer olestra.
    Allgood GS; Kuter DJ; Roll KT; Taylor SL; Zorich NL
    Regul Toxicol Pharmacol; 2001 Apr; 33(2):224-33. PubMed ID: 11350205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.